5B9单克隆抗体作为HIT功能试验内部质控的多中心评估
该多中心研究将模拟人类HIT抗体的单克隆抗PF4/肝素IgG 5B9发放至七国11个实验室,用HIPA、SRA、PAT、FC或HIMEA检测6个初始浓度(10–400 μg/mL)。结果显示HIT功能试验标准化不足,但5B9有望用于标准化功能试验和筛选反应性血小板供者。
要点
- 5B9在多数中心HIPA、SRA或HIMEA中≥100 μg/mL时获阳性结果
- FC和PAT结果异质性较大,标准化程度不足
- 5B9可用于标准化HIT功能试验及筛选反应性血小板供者
核心结论
- HIT功能试验标准化不佳,对血小板活化抗体检测灵敏度存在差异。
- 5B9是潜在有用的工具,可标准化功能试验、筛选反应性血小板供者并提高实验室间可比性。
研究设计与样本
- 多中心研究,5B9发放至七国11个实验室。
- 测试6个初始浓度10–400 μg/mL,方法包括HIPA、SRA、PAT、FC或HIMEA。
- 每种方法在三个不同实验室评估,使用10名不同健康供者血小板,操作流程与常规HIT诊断相同。
主要发现
- 各实验室操作流程存在差异,尤其使用富血小板血浆和全血时。
- 多数中心HIPA、SRA或HIMEA在5B9≥100 μg/mL时对多数供者获阳性结果(一个中心除外)。
- FC和PAT结果更异质:一中心用洗涤血小板预孵育PF4时50 μg/mL 5B9对所有供者阳性,PAT多数供者需≥200 μg/mL。
关键数值与推荐
- 5B9初始浓度范围10–400 μg/mL。
- HIPA、SRA或HIMEA多数中心在≥100 μg/mL获阳性。
- FC一中心在50 μg/mL对所有供者阳性;PAT多数供者需≥200 μg/mL。
临床怎么用
- 可将5B9作为HIT功能试验的内部质控品。
- 可用5B9筛选对血小板活化试验有反应的血小板供者。
- 有助于提高HIT功能试验性能和实验室间可比性。
局限性
- 各实验室操作流程存在差异,尤其富血小板血浆和全血方法。
- FC和PAT结果异质性较大,标准化难度较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Functional tests for the diagnosis of heparin-induced thrombocytopenia (HIT) exhibit variable performance. OBJECTIVES: We evaluated in a multicenter study whether 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, could be used as an internal quality control. METHODS: 5B9 was sent to 11 laboratories in seven countries, and six initial concentrations ranging from 10 to 400 μg/mL were tested by heparin-induced platelet activation assay (HIPA), serotonin release assay (SRA), platelet aggregation test (PAT), flow cytometry (FC), or heparin-induced multiple-electrode aggregometry (HIMEA). Each method was evaluated in three different laboratories using experimental procedures identical to those usually applied for the diagnosis of HIT by testing platelets from 10 different healthy donors. RESULTS: The procedures used varied among the laboratories, particularly when platelet-rich plasma and whole blood were used. Nevertheless, positive results were obtained with at least 100 μg/ml of 5B9 for most donors tested by all centers (except one) performing HIPA, SRA, or HIMEA. FC and PAT results were more heterogeneous. FC results from one center that used washed platelets preincubated with PF4 were positive with all donors at 50 µg/ml 5B9, but at least 200 μg/ml of 5B9 were required to activate cells with most donors tested using PAT. CONCLUSION: This study confirms that HIT functional tests are not well standardized and exhibit variable sensitivity for the detection of platelet-activating antibodies. However, 5B9 is a potentially useful tool to standardize functional tests, to select responding platelet donors, and consequently to improve the performance of these assays and comparability between laboratories.
引用
- Pouplard C, Rollin J, Vayne C, et al. Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost. 2021. PMID: 34657390. doi:10.1111/jth.15560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。